Cordycepin

DB12156InvestigationalSmall molecule

Cordycepin has been used in trials studying the treatment of Leukemia.

Mechanism: Pharmacologically active on Poly(A) polymerase alpha and 5'-AMP-activated protein kinase
Curator reviewed
Formula / weight: C₁₀H₁₃N₅O₃ · 251.2419 g/mol (avg)
Code names: NSC-401022 · NSC-63984 · PRaG-1

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyOFEZSBMBBKLLBJ-BAJZRUMYSA-NSMILES[H][C@@]1(CO)C[C@@]([H])(O)[C@@]([H])(O1)N1C=NC2=C(N)N=CN=C12

Targets

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

53Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cordycepin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.